Vaccinology During and After COVID-19
September 17-20, 2023 | Atlanta Marriott Marquis, Atlanta, GA, United States
Scientific Organizers:
Bali Pulendran, Robert A. Seder and Gagandeep Kang
Livestream
In Person
On Demand
September 17-20, 2023 | Atlanta Marriott Marquis, Atlanta, GA, United States
Scientific Organizers:
Bali Pulendran, Robert A. Seder and Gagandeep Kang
Available Formats:
Livestream
In Person
On Demand
Supported by the Directors' Fund
Available Formats: = Livestream = In Person = On Demand
Booking Function
Fundraising
Sunday, September 17, 2023
Arrival and Registration
4:00–8:00 PM
International Salon Foyer
Welcome Remarks
6:00–6:15 PM
International Salon Foyer
Welcome Mixer
6:00–8:00 PM
International Salon Foyer
* Bali Pulendran, Stanford University School of Medicine
Session Chair
Session Chair
Barney S. Graham, Morehouse School of Medicine
Vaccine Equity and the Future of Global Health
Vaccine Equity and the Future of Global Health
* Maria Elena Bottazzi, Baylor College of Medicine
Session Chair
Session Chair
* Dan H. Barouch, Beth Israel Deaconess Medical Center
Session Chair
Session Chair
Maria Elena Bottazzi, Baylor College of Medicine
COVID-19 Vaccine Technologies Bolstering the Development of Neglected Tropical Disease Vaccines
COVID-19 Vaccine Technologies Bolstering the Development of Neglected Tropical Disease Vaccines
Dan H. Barouch, Beth Israel Deaconess Medical Center
Correlates of Protection for COVID-19 Vaccines
Correlates of Protection for COVID-19 Vaccines
Jay K. Kolls, Tulane School of Medicine
Clinical Development of an Intranasal Pneumonia Vaccine that Targets Th17 TRM Cells
Clinical Development of an Intranasal Pneumonia Vaccine that Targets Th17 TRM Cells
Tyler D Gavitt, Duke University School of Medicine
Short Talk: A Trivalent RBD-nanoparticle Vaccine Elicits Protective Immunity against Three Human-pathogenic Coronavirus Species in Mice
Short Talk: A Trivalent RBD-nanoparticle Vaccine Elicits Protective Immunity against Three Human-pathogenic Coronavirus Species in Mice
Monday, September 18, 2023
Breakfast
7:30–8:30 AM
International Salon 1-3
Poster Setup
8:00–8:30 AM
International Salon 7-10
Poster Viewing
8:30–7:00 PM
International Salon 7-10
Welcome and Keynote Address
8:30–9:30 AM
International Salon 4-6
* Jay K. Kolls, Tulane School of Medicine
Session Chair
Session Chair
* Chinnaswamy Jagannath, Houston Methodist Research Institute
Session Chair
Session Chair
Frank Wegmann, Janssen Vaccines & Prevention
Mucosal Boosting Enhances Vaccine Protection Against SARS-CoV-2 in Rhesus Macaques
Mucosal Boosting Enhances Vaccine Protection Against SARS-CoV-2 in Rhesus Macaques
Chinnaswamy Jagannath, Houston Methodist Research Institute
A Self-adjuvated Vaccine Induces Multiple Pathways of Innate Immunity Protecting Mice against Tuberculosis
A Self-adjuvated Vaccine Induces Multiple Pathways of Innate Immunity Protecting Mice against Tuberculosis
Fredrika Hellgren, Karolinska Institutet
Prior SARS-CoV-2 Infection Modulates the Early Inflammatory Response to mRNA Vaccination
Prior SARS-CoV-2 Infection Modulates the Early Inflammatory Response to mRNA Vaccination
Yupeng Feng, Stanford University
Evolution of Antibody Immunity to Subunit COVID-19 Vaccines
Evolution of Antibody Immunity to Subunit COVID-19 Vaccines
Pritesh Desai, Washington University
Intestinal Helminth Infection Impairs Vaccine-induced T Cell Responses and Protection against a SARS-CoV-2 Omicron Variant in Mice
Intestinal Helminth Infection Impairs Vaccine-induced T Cell Responses and Protection against a SARS-CoV-2 Omicron Variant in Mice
Cuiping (Catherine) Liu, NIH
Genetic Immunization with Self-Assembling SARS-CoV-2 Spike-HBsAg Nanoparticles
Genetic Immunization with Self-Assembling SARS-CoV-2 Spike-HBsAg Nanoparticles
Vaccine Platforms for COVID-19 and Beyond
9:30–11:45 AM
International Salon 4-6
Coffee Break
10:00–10:20 AM
International Salon Foyer
* Pamela J. Bjorkman, California Institute of Technology
Session Chair
Session Chair
Pamela J. Bjorkman, California Institute of Technology
Towards a Vaccine Against Animal Sarbecoviruses and SARS-CoV2 Variants that would not need Updating
Towards a Vaccine Against Animal Sarbecoviruses and SARS-CoV2 Variants that would not need Updating
Barton F. Haynes, Duke University Medical Center
Strategy for the Development of Pancoronavirus Vaccines: Immunogen Designs and Protective Immune Responses
Strategy for the Development of Pancoronavirus Vaccines: Immunogen Designs and Protective Immune Responses
Ankita Leekha, University of Houston
Short Talk: Ending Transmission: Multi-antigen Intranasal Vaccines Protect against Challenge by Diverse Sarbecoviruses
Short Talk: Ending Transmission: Multi-antigen Intranasal Vaccines Protect against Challenge by Diverse Sarbecoviruses
Harry Kleanthous, SK Biosciences
A Nanoparticle based Pan Coronavirus and Influenza Vaccines
A Nanoparticle based Pan Coronavirus and Influenza Vaccines
Lunch
11:45–1:00 PM
International Salon 7-10
Poster Session 1
12:30–2:30 PM
International Salon 7-10
Workshop 1: Immune Responses to Vaccination
2:30–4:30 PM
International Salon 4-6
Coffee Available
4:30–5:00 PM
International Salon Foyer
Pan Pathogen Vaccines
5:00–7:00 PM
International Salon 4-6
* Mala K. Maini, University College London
Session Chair
Session Chair
* Donna L. Farber, Columbia University Medical Center
Session Chair
Session Chair
Alessandro Sette, La Jolla Institute for Immunology
Breakthrough Infection Enhances Sars-Cov-2-Specific T Cell Responses and Generates Novel Epitope Specificities
Breakthrough Infection Enhances Sars-Cov-2-Specific T Cell Responses and Generates Novel Epitope Specificities
Robert A. Seder, NIAID, National Institutes of Health
T Cell Quality in Memory and Protection
T Cell Quality in Memory and Protection
Donna L. Farber, Columbia University Medical Center
Durable Vaccine Immunity in Human Tissues
Durable Vaccine Immunity in Human Tissues
Mala K. Maini, University College London
T Cell based COVID Protection Before and after the Pandemic
T Cell based COVID Protection Before and after the Pandemic
Laura Su, University of Pennsylvania
Pre-Existing Memory in Vaccine Responses
Pre-Existing Memory in Vaccine Responses
Tuesday, September 19, 2023
Rino Rappuoli, Fondazione Biotecnopolo di Siena
Scientific Director
Scientific Director
Maria Elena Bottazzi, Baylor College of Medicine
Associate Dean & Professor
Associate Dean & Professor
Galit Alter, Moderna, Inc.
Vice President of Immunology Research
Vice President of Immunology Research
Laura Su, University of Pennsylvania
Assistant Professor & Physician
Assistant Professor & Physician
Breakfast
7:30–8:30 AM
International Salon 1-3
T-Cell Based Vaccines
8:30–11:30 AM
International Salon 4-6
* Gagandeep Kang, Bill and Melinda Gates Foundation
Session Chair
Session Chair
Fan Zhou, University of Bergen
Age Related Differences in Kinetics and Magnitude of SARS-CoV-2 and Endemic Human Coronavirus Reactive Antibody Responses After Vaccination and Infection
Age Related Differences in Kinetics and Magnitude of SARS-CoV-2 and Endemic Human Coronavirus Reactive Antibody Responses After Vaccination and Infection
Lobke Hensen, University Medical Center Utrecht
T Cell Immune Response Induced by Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Down Syndrome
T Cell Immune Response Induced by Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Down Syndrome
Francesco Berlanda Scorza, Gsk Vaccines Institute For Global Health Srl (Gvgh)
A Strategic Model and Industry Collaboration for Sustainable Development of Vaccines against Neglected Diseases
A Strategic Model and Industry Collaboration for Sustainable Development of Vaccines against Neglected Diseases
Jerome Nyhalah Dinga, University of Buea
Combating the Loss in Childhood Immunization Gains in Rural Communities and Vaccination of Disabled Persons due to Covid-19: The Approach of Building Relationships and Harnessing Power in the Community
Combating the Loss in Childhood Immunization Gains in Rural Communities and Vaccination of Disabled Persons due to Covid-19: The Approach of Building Relationships and Harnessing Power in the Community
Ramya Madhavan, Christian Medical College
Humoral Immune Response Elicited by Mix-and-Match SARS-CoV-2 Vaccination Strategies in India
Humoral Immune Response Elicited by Mix-and-Match SARS-CoV-2 Vaccination Strategies in India
Coffee Break
9:30–9:50 AM
International Salon Foyer
* Shane Crotty, La Jolla Institute for Immunology
Session Chair
Session Chair
* Rafi Ahmed, Emory University School of Medicine
Session Chair
Session Chair
Rafi Ahmed, Emory University School of Medicine
Durability of Immune Responses to Vaccination and Infection
Durability of Immune Responses to Vaccination and Infection
Shane Crotty, La Jolla Institute for Immunology
Immune Memory to Infection and COVID-19 Vaccination
Immune Memory to Infection and COVID-19 Vaccination
Grace Hendricks, University of Washington
Short Talk: Computationally Designed mRNA-launched Nanoparticle Vaccines
Short Talk: Computationally Designed mRNA-launched Nanoparticle Vaccines
Vamsee Mallajosyula, Stanford University
Short Talk: Broadening T Cell Help by Antigen Crosslinking as a Universal Vaccine Platform against Rapidly Evolving Pathogenic Viruses
Short Talk: Broadening T Cell Help by Antigen Crosslinking as a Universal Vaccine Platform against Rapidly Evolving Pathogenic Viruses
Elizabeth Thompson, Johns Hopkins University
Short Talk: Balanced Lipid Synthesis and Oxidation Support Vaccine Responses in Solid Organ Transplant Recipients
Short Talk: Balanced Lipid Synthesis and Oxidation Support Vaccine Responses in Solid Organ Transplant Recipients
Sandhya Bangaru, The Scripps Research Institute
Short Talk: Structural Evaluation of Serum Polyclonal Antibody Responses to mRNA-1273 and NVX-CoV2373 Vaccines
Short Talk: Structural Evaluation of Serum Polyclonal Antibody Responses to mRNA-1273 and NVX-CoV2373 Vaccines
On Own for Lunch
11:30–5:00 PM
Poster Setup
11:30–1:00 PM
International Salon 7-10
Poster Viewing
1:00–10:00 PM
International Salon 7-10
Career Roundtable
1:00–2:00 PM
International Salon 4-6
Workshop 2: Equity in Vaccine Responses
3:00–4:30 PM
International Salon 4-6
Coffee Available
4:30–5:00 PM
International Salon Foyer
B Cell and Antibody Responses To Vaccination
5:00–7:00 PM
International Salon 4-6
Social Hour with Lite Bites
7:00–8:15 PM
International Salon 7-10
Poster Session 2
7:30–10:00 PM
International Salon 7-10
* Galit Alter, Moderna, Inc.
Session Chair
Session Chair
* Karin Loré, Karolinska Institutet
Session Chair
Session Chair
Bali Pulendran, Stanford University School of Medicine
Innate Immune Predictors and Mechanisms of Vaccination
Innate Immune Predictors and Mechanisms of Vaccination
Galit Alter, Moderna, Inc.
Structural and Functional Determinants of Antibody Responses to Vaccination and Infection
Structural and Functional Determinants of Antibody Responses to Vaccination and Infection
Karin Loré, Karolinska Institutet
Immune Responses Elicited by mRNA Vaccines Compared to Traditional Vaccine Platforms
Immune Responses Elicited by mRNA Vaccines Compared to Traditional Vaccine Platforms
Mark M. Davis, Stanford University School of Medicine, Howard Hughes
Measuring Vaccine Immunity in a Dish
Measuring Vaccine Immunity in a Dish
Paola A Lopez Zapana, MIT
Short Talk: Placental Transfer and Durability of Maternal COVID-19 Vaccine-induced Antibodies in Infants through 6 Months of Age
Short Talk: Placental Transfer and Durability of Maternal COVID-19 Vaccine-induced Antibodies in Infants through 6 Months of Age
Katerina Roznik, Johns Hopkins University
Short Talk: Hepatitis C Virus Vaccine Immunogenicity in People who Inject Drugs: Investigating the Impact of Opioids on Dysregulated Neutrophil and T Cell Function
Short Talk: Hepatitis C Virus Vaccine Immunogenicity in People who Inject Drugs: Investigating the Impact of Opioids on Dysregulated Neutrophil and T Cell Function
Wednesday, September 20, 2023
Breakfast
7:30–8:30 AM
International Salon 1-3
Measuring and Predicting Immunity to Vaccination
8:30–11:30 AM
International Salon 4-6
* Bali Pulendran, Stanford University School of Medicine
Session Chair
Session Chair
* Robert A. Seder, NIAID, National Institutes of Health
Session Chair
Session Chair
Slim Fourati, Northwestern University
Pan-vaccine Analysis Reveals Innate Immune Endotypes Predictive of Antibody Responses to Vaccination
Pan-vaccine Analysis Reveals Innate Immune Endotypes Predictive of Antibody Responses to Vaccination
Thomas Hagan, Cincinnati Children's Hospital
Transcriptional Atlas of the Human Immune Response to 13 Vaccines
Transcriptional Atlas of the Human Immune Response to 13 Vaccines
Hyun Jik Kim, Seoul National University College of Medicine
Distinct Interferon-related Innate Immune Signatures in the Nasopharynx of COVID-19 Patients Depending on Disease Severity or Vaccine History
Distinct Interferon-related Innate Immune Signatures in the Nasopharynx of COVID-19 Patients Depending on Disease Severity or Vaccine History
Vicki Stylianou, Westmead Institute for Medical Research
Adjuvant AS01 Activates Subcapsular Sinus Macrophages and Dendritic Cells in Human Lymph Node Explants
Adjuvant AS01 Activates Subcapsular Sinus Macrophages and Dendritic Cells in Human Lymph Node Explants
Camila Coelho, Icahn School of Medicine at Mount Sinai
Mpox Vaccine and Infection-Driven Human Immune Signatures
Mpox Vaccine and Infection-Driven Human Immune Signatures
Sanya Thomas, Boston Children's Hospital/Harvard Medical School
Human in vitro Modeling Characterizes Mechanism of Action of Adjuvantation Systems Defining Scalable and Affordable Precision Vaccine Formulations for Early Childhood
Human in vitro Modeling Characterizes Mechanism of Action of Adjuvantation Systems Defining Scalable and Affordable Precision Vaccine Formulations for Early Childhood
Antonella Prisco, National Research Council
Evaluation of COVID-19 Vaccination Protocols in an Agent-based Immune Simulation Platform
Evaluation of COVID-19 Vaccination Protocols in an Agent-based Immune Simulation Platform
Coffee Break
9:30–9:50 AM
International Salon Foyer
* Rino Rappuoli, Fondazione Biotecnopolo di Siena
Session Chair
Session Chair
Gagandeep Kang, Bill and Melinda Gates Foundation
Enhancing Vaccine Equity Before and After COVID-19
Enhancing Vaccine Equity Before and After COVID-19
Rino Rappuoli, Fondazione Biotecnopolo di Siena
Preparing for the Next Pandemic
Preparing for the Next Pandemic
Nadia Rachel Cohen, CEPI
The CEPI Portfolio and Ecosystem Supports Development of Coronavirus Vaccines
The CEPI Portfolio and Ecosystem Supports Development of Coronavirus Vaccines
On Own for Lunch
11:30–5:00 PM
Workshop 3: Measuring and Predicting Immunity to Vaccination and Infection
2:30–4:30 PM
International Salon 4-6
Coffee Available
4:30–5:00 PM
International Salon Foyer
Vaccinology in the Post-COVID Era
5:00–6:45 PM
International Salon 4-6
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
6:45–7:00 PM
International Salon 4-6
Social Hour with Lite Bites
7:00–8:00 PM
International Salon 7-10
Cash Bar
8:00–9:00 PM
International Salon 7-10
Thursday, September 21, 2023
Departure
7:00–11:59 PM
Merchandise Options
Registration Options
Subscribe for Updates